The Federal Trade Commission and the U.S. DOJ Antitrust Division during the Biden Administration Have Significantly Ramped Up Antitrust Enforcement: Non-Antitrust Lawyers Beware! October 9, 2023
Federal Trade Commission Expands Requirements for Reporting Pharmaceutical Patent License Transactions November 22, 2013